Brief: Crescita Therapeutics Receives 2nd Installment Of Up-Front Pay Of €1.25 Mln After First Commercial Sale Of Pliaglis By Cantabria In Italy
04/07/2019 12:36
July 4 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS INC. RECEIVES 2ND INSTALMENT OF
UP-FRONT
PAYMENT OF €1.25 MILLION FOLLOWING FIRST COMMERCIAL SALE OF
PLIAGLIS BY CANTABRIA IN ITALY
Source text for Eikon: ID:nCNWlk5tYa
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium